Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,984 public trials 1,831 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Recruiting

An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context

NCT06720870

Conditions: Castleman Disease, Hemic and Lymphatic Diseases, Immune System Diseases, +3 more
Locations: IRCCS Azienda Ospedaliero - Universitaria di Bologna Bologna, Italy

Azienda Ospedaliera Sant'Anna e San Sebastiano Caserta, Italy

Policlinico di Bari - Azienda Ospedaliero Universitaria Consorziale Policlinico Bari, Italy

Azienda Ospedaliera Universitaria Arcispedale Sant'Anna Ferrara, Italy

View Trial Details

Recruiting

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research

NCT06716164

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

NCT06534463

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Shanghai Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Radiotherapy Followed by Tiselizumab Combined With RCHOP in Previously Untreated Bulky Follicular Lymphoma

NCT06704555

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Tianjin Cancer Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)

NCT06698484

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Universiti Kebangsaan Malaysia Bandar Tun Razak, Kuala Lumpur, Malaysia

View Trial Details

Recruiting

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

NCT05333367

Conditions: Cutaneous T-Cell Lymphoma, Graft Rejection, Graft vs Host Disease, +11 more
Locations: Centre Hospitalier Universitaire de Besançon Besançon, France

View Trial Details

Recruiting

MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL)

NCT04110301

Conditions: Follicular Lymphoma and Marginal Zone Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

NCT06696833

Conditions: B-Cell Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, China, Jiangsu, China

View Trial Details

Recruiting

MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma

NCT04834024

Conditions: Follicular Lymphoma and Marginal Zone Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China

View Trial Details

Recruiting

A Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy Study of MBS303 in B-Cell NHL

NCT05806099

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Beijing Cancer Hospital Beijing, China

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions